<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02246556</url>
  </required_header>
  <id_info>
    <org_study_id>14-14212</org_study_id>
    <secondary_id>093955</secondary_id>
    <nct_id>NCT02246556</nct_id>
  </id_info>
  <brief_title>Dichoptic Virtual Reality Therapy for Amblyopia in Adults</brief_title>
  <official_title>Dichoptic Virtual Reality Therapy for Amblyopia in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a randomized, masked, controlled study of the effect of a virtual reality,
      binocular, 3-dimensional video game on visual acuity and stereopsis in adult patients with
      amblyopia. The trial has been halted as of June 2016 and will not be evaluating any new
      subjects for enrollment.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment inadequate and investigators leaving the study institution for new positions.
  </why_stopped>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in visual acuity</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in stereopsis</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 weeks, 6 weeks, and 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Amblyopia</condition>
  <condition>Anisometropia</condition>
  <condition>Strabismus</condition>
  <arm_group>
    <arm_group_label>Patching therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patching treatment followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dioptic (non-dichoptic) therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dioptic (non-dichoptic) therapy followed by crossover to dichoptic virtual reality video game treatment arm using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dichoptic therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dichoptic virtual reality video game treatment using Diplopia (TM) software developed for the Oculus Rift (R) game system.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dichoptic therapy</intervention_name>
    <description>Dichoptic virtual reality video game therapy with Diplopoia (TM) software developed for the Oculus Rift (R) gaming system</description>
    <arm_group_label>Dichoptic therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patching therapy</intervention_name>
    <description>Conventional patching therapy followed by crossover to the dichoptic virtual reality video game therapy with Diplopia (TM) software</description>
    <arm_group_label>Patching therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dioptic (non-dichoptic) therapy</intervention_name>
    <description>Dioptic (non-dichoptic) video game therapy followed by crossover to the dichoptic virtual reality video game therapy with Diplopia (TM) software</description>
    <arm_group_label>Dioptic (non-dichoptic) therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Interpupillary distance of 60-66 mm

          -  Age 15-40

          -  Anisometropic amblyopia or strabismic amblyopia

          -  Best corrected visual acuity of 20/30 or worse in the amblyopic eye

          -  No prior therapeutic use of the software

          -  No other ongoing therapies including patching or recent eye muscle surgery

          -  No vested interest in the product

          -  Ability attend visits and complete the training session, and to stop the intervention
             after the specified intervention period

        Exclusion Criteria:

          -  Stimulus-deprivation amblyopia.

          -  Organic lesions of the eye preventing the establishment of good vision (eg. media
             opacities, abnormalities in the fundus or optic nerve).

          -  Lesions of the brain preventing the establishment of good vision (eg. cortical visual
             impairment).

          -  Establishment of normal vision by refractive adaptation (wearing glasses after
             presentation).

          -  Patients diagnosed with Photosensitive Epilepsy.

          -  Inability to comply with the follow-up visits required.

          -  History of pathologic nystagmus (congenital or sensory).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2014</study_first_submitted>
  <study_first_submitted_qc>September 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2014</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Marc Levin</investigator_full_name>
    <investigator_title>Assistant Professor, Neuro-ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Amblyopia</keyword>
  <keyword>Dichoptic</keyword>
  <keyword>Virtual reality</keyword>
  <keyword>Stereopsis</keyword>
  <keyword>Stereo vision</keyword>
  <keyword>Visual acuity</keyword>
  <keyword>Binocular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
    <mesh_term>Strabismus</mesh_term>
    <mesh_term>Anisometropia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

